

03 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/03/3248574/0/en/Persevere-Therapeutics-Launches-as-a-Clinical-Stage-Oncology-Company-with-a-Novel-Phase-1b-2a-Agent-and-Announces-First-Close-of-Seed-Financing.html

13 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/13/3098968/0/en/Panavance-Therapeutics-Announces-Promising-Misetionamide-GP-2250-Phase-1-Clinical-Trial-Interim-Findings-in-Pancreatic-Cancer-at-BIO-2025.html